gsk aims aids profiteers
largest manufacturers drugs launched initiative combat smuggling cheaper pills supplied poorer african countries europe resale price
company glaxosmithkline alter packaging change colour pills provided developing nations humanitarian agreement estimated drugs companies losing hundreds millions dollars result diversion products sensitive drugs companies maintain profits tremendous pressure provide cheap drugs poorest nations
result drugs supplied africa thirty times cheaper sold europe bringing medicines reach millions africans government health care systems
wide difference price gains illegally diverting cheaper drugs wealthier countries price glaxosmithkline believes coating pills destined africa red dye adding identification codes pills packaging trade reduced company identify specific distributors africa humanitarian drugs profit suppliers europe involved trade glaxo distribution drugs begun chemical content identical sold europe
